tiprankstipranks

Karen Akinsanya Insider Profile

4 Followers
Karen Akinsanya, President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships at Schrodinger, holds 69.96K shares in Schrodinger (Ticker: SDGR), holds ― shares in Nautilus Biotechnolgy (Ticker: NAUT).
tipranks
Karen Akinsanya

Karen Akinsanya
Schrodinger (SDGR)
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships

Not Ranked
Karen Akinsanya has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$795K
100.00%
0.00%
A breakdown of Karen Akinsanya's holdings

Insider Roles

Schrodinger
(SDGR)
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Nautilus Biotechnolgy
(NAUT)
Director
Roles that Karen Akinsanya holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Karen Akinsanya

Karen Akinsanya's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Schrodinger
Mar 06, 2026
President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Uninformative Sell
17.62K
$795.40K
Nautilus Biotechnolgy
Director
List of latest transactions for each holding click on a transaction to see Karen Akinsanya's performance on stock

Karen Akinsanya insider profile FAQ

What is the percentage of profitable transactions made by Karen Akinsanya?
The percentage of profitable transactions made by Karen Akinsanya is ―.
    What is the average return per transaction made by Karen Akinsanya?
    The average return per transaction made by Karen Akinsanya is ―.
      What stocks does Karen Akinsanya hold?
      Karen Akinsanya holds: SDGR, NAUT stocks.
        What was Karen Akinsanya’s latest transaction?
        Karen Akinsanya latest transaction was an Uninformative Sell of $17.62K.
          What was Karen Akinsanya's most profitable transaction?
          Karen Akinsanya’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Karen Akinsanya's role in Schrodinger?
            Karen Akinsanya's role in Schrodinger is President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.